African Pharmaceutical Regulatory Intelligence

FLUTICASONE PROPIONATE & SALMETEROL XINAFOATE

25 registrations across 4 African markets— 23 active

Markets with FLUTICASONE PROPIONATE & SALMETEROL XINAFOATE

🇬🇭Ghana

Recent registrations

Brand / Product	Market	Holder	Status	Expires
SEROCORT 250 SYNCHROBREATHE SB (Each actuation contains Fluticasone Propionate/Salmeterol Xinafoate 250mcg/25mcg)	🇬🇭Ghana	—	active	Feb 2031
SEROCORT 250 SYNCHROBREATHE SB (Each actuation contains Fluticasone Propionate/Salmeterol Xinafoate 250mcg/25mcg)	🇬🇭Ghana	—	active	Feb 2031
SEROCORT 125 SYNCHROBREATHE SB (Each actuation contains Fluticasone Propionate/Salmeterol Xinafoate 125mcg/25mcg)	🇬🇭Ghana	—	active	Feb 2031
SEROCORT 125 SYNCHROBREATHE SB (Each actuation contains Fluticasone Propionate/Salmeterol Xinafoate 125mcg/25mcg)	🇬🇭Ghana	—	active	Feb 2031
METRICASON 50/25MCG AEROSOL; INHALATION	🇿🇼Zimbabwe	COSPHARM INVESTMENTS PVT LTD	active	Feb 2030
METRICASON 250/25MCG AEROSOL; INHALATION	🇿🇼Zimbabwe	COSPHARM INVESTMENTS PVT LTD	active	Feb 2030
METRICASONE 125/25MCG AEROSOL; INHALATION	🇿🇼Zimbabwe	COSPHARM INVESTMENTS PVT LTD	active	Feb 2030
COMBIWAVE SF INHALATION	🇿🇼Zimbabwe	GLENMARK PHARMACEUTICAL LIMITED	active	May 2029
COMBIWAVE SF 250 INHALATION	🇿🇼Zimbabwe	GLENMARK PHARMACEUTICAL LIMITED	active	May 2029
FLUZOMEX 250 INHALATION AEROSOL	🇬🇭Ghana	—	active	Aug 2028
FLUZOMEX 125 INHALATION AEROSOL	🇬🇭Ghana	—	active	Aug 2028
FLUZOMEX 250 INHALATION AEROSOL	🇬🇭Ghana	—	active	Aug 2028
FLUZOMEX 125 INHALATION AEROSOL	🇬🇭Ghana	—	active	Aug 2028
AVASALF 500/50 INHALATION	🇿🇼Zimbabwe	INNOVATA PHARMACEUTICALS LTD	active	Dec 2027
AVASALF 100/50 INHALATION	🇿🇼Zimbabwe	INNOVATA PHARMACEUTICALS LTD	active	Dec 2027
AVASALF 250/50 INHALATION	🇿🇼Zimbabwe	INNOVATA PHARMACEUTICALS LTD	active	Dec 2027
SERETIDE ACCUHALER INHALATION POWDER ( Fluticasone Propionate/Salmeterol Xinafoate 100mcg/50mcg)	🇬🇭Ghana	—	active	Dec 2026
SERETIDE ACCUHALER INHALATION POWDER ( Fluticasone Propionate/Salmeterol Xinafoate 100mcg/50mcg)	🇬🇭Ghana	—	active	Dec 2026
SERETIDE ACCUHALER INHALATION POWDER	🇬🇭Ghana	—	active	Dec 2026
SERETIDE ACCUHALER INHALATION POWDER ( Fluticasone Propionate/Salmeterol Xinafoate 250mcg/50mcg)	🇬🇭Ghana	—	active	Dec 2026
SERETIDE ACCUHALER INHALATION POWDER ( Fluticasone Propionate/Salmeterol Xinafoate 250mcg/50mcg)	🇬🇭Ghana	—	active	Dec 2026
SERETIDE ACCUHALER INHALATION POWDER	🇬🇭Ghana	—	active	Dec 2026
RESPTOL 250/50mcg INHALATION POWDER INHALATION POWDER	🇲🇼Malawi	—	expired	Mar 2024
RESPTOL 500/50mcg INHALATION POWDER INHALATION POWDER	🇲🇼Malawi	—	expired	Mar 2022
CYVAX suspension pour inhalation / 250 µg / 25 µg	🇸🇳Senegal	BERG LIFE SCIENCES SA	active	—

FLUTICASONE PROPIONATE & SALMETEROL XINAFOATE in Africa — Regulatory Overview

FLUTICASONE PROPIONATE & SALMETEROL XINAFOATE is registered across 4 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Zimbabwe, Malawi, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 25 registrations, 23 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.